US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6183778B1
(en)
*
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
GB9402203D0
(en)
*
|
1994-02-04 |
1994-03-30 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
GB9407386D0
(en)
|
1994-04-14 |
1994-06-08 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US6121276A
(en)
*
|
1994-04-22 |
2000-09-19 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
|
GB9416599D0
(en)
*
|
1994-08-17 |
1994-10-12 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
GB9416600D0
(en)
|
1994-08-17 |
1994-10-12 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US5534263A
(en)
*
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5985843A
(en)
*
|
1995-04-03 |
1999-11-16 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition containing sucralfate
|
US20030109503A1
(en)
*
|
1995-06-06 |
2003-06-12 |
Smithkline Beecham P.L.C. |
Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
|
IT1276689B1
(it)
*
|
1995-06-09 |
1997-11-03 |
Applied Pharma Res |
Forma farmaceutica solida ad uso orale
|
IT1282576B1
(it)
*
|
1996-02-06 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
|
IT1282650B1
(it)
*
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
GB9613470D0
(en)
*
|
1996-06-27 |
1996-08-28 |
Ciba Geigy Ag |
Small solid oral dosage form
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
IL119627A
(en)
|
1996-11-17 |
2002-03-10 |
Yissum Res Dev Co |
PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
|
EP0951278A2
(en)
*
|
1997-01-03 |
1999-10-27 |
ELAN CORPORATION, Plc |
Sustained release cisapride mini-tablet formulation
|
US20030124187A1
(en)
*
|
1997-02-14 |
2003-07-03 |
Smithkline Beecham Laboratoires Pharmaceutiques, |
Pharmaceutical formulations comprising amoxycillin and clavulanate
|
BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
US6756056B2
(en)
*
|
1997-04-08 |
2004-06-29 |
Alan A. Rubin |
Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa
|
US6046177A
(en)
*
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
AR016827A1
(es)
|
1997-08-22 |
2001-08-01 |
Smithkline Beecham Corp |
PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
|
AR017512A1
(es)
|
1997-08-22 |
2001-09-12 |
Smithkline Beecham Corp |
Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
|
RS49982B
(sr)
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
IN186245B
(it)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
IT1295271B1
(it)
*
|
1997-10-03 |
1999-05-04 |
Chiesi Farma Spa |
Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
|
DE19816070A1
(de)
|
1998-04-09 |
1999-10-14 |
Aventis Res & Tech Gmbh & Co |
Retardtablette hergestellt aus linearen wasserunlöslichen Polysacchariden
|
DE69802260T2
(de)
|
1998-04-30 |
2002-07-04 |
Vesely Renata Maria Cavaliere |
Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
|
JP2010024239A
(ja)
*
|
1998-05-06 |
2010-02-04 |
Kowa Co |
消化管運動抑制剤
|
FR2779651B1
(fr)
|
1998-06-16 |
2001-04-20 |
Gattefosse Ets Sa |
Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
WO2000015197A1
(en)
*
|
1998-09-14 |
2000-03-23 |
Rubin Alan A |
Improvement in treatment of parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa
|
AU761281B2
(en)
*
|
1998-09-25 |
2003-05-29 |
Delsys Pharmaceutical Corporation |
Liquid pharmaceutical for oral delivery
|
DE60017363T2
(de)
|
1999-02-02 |
2006-03-02 |
Wright Medical Technology Inc., Arlington |
Kontrollierte freisetzung eines verbundmaterials
|
US6432448B1
(en)
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
FI4823U1
(fi)
*
|
1999-04-13 |
2001-02-16 |
Beecham Pharm Pte Ltd |
Muunnetulla tavalla vapauttava lääkeformulaatio
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
US7250176B1
(en)
*
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
US6294199B1
(en)
*
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
MY125516A
(en)
*
|
1999-11-16 |
2006-08-30 |
Smithkline Beecham Plc |
Novel composition based on thiazolidinedione and metformin and use
|
MXPA02007254A
(es)
|
2000-02-04 |
2002-12-09 |
Depomed Inc |
Forma de dosis de cubierta-y-nucleo que se aproxima a liberacion de droga de orden cero.
|
US6458384B2
(en)
|
2000-02-23 |
2002-10-01 |
Impetus Ag |
Pharmaceutical with predetermined activity profile
|
US6623757B2
(en)
*
|
2000-02-24 |
2003-09-23 |
Advancis Pharmaceutical Corp. |
Antibiotic composition
|
AR030557A1
(es)
*
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
US8012504B2
(en)
*
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US7838032B2
(en)
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US7985420B2
(en)
*
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
DE10031043A1
(de)
*
|
2000-06-26 |
2002-02-14 |
Bayer Ag |
Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
|
US7130822B1
(en)
*
|
2000-07-31 |
2006-10-31 |
Cognos Incorporated |
Budget planning
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
EP1330236A2
(en)
|
2000-10-12 |
2003-07-30 |
Beecham Pharmaceuticals (Pte) Limited |
Formulation containing amoxicillin
|
IL155959A0
(en)
|
2000-11-28 |
2003-12-23 |
Fmc Corp |
Edible pga (propylene glycol alginate) coating composition
|
US20030143272A1
(en)
*
|
2001-03-14 |
2003-07-31 |
Waterman Kenneth C. |
Pharmaceutical tablet and process for making thereof
|
EP1240897B1
(en)
*
|
2001-03-14 |
2006-06-21 |
Pfizer Products Inc. |
Pharmaceutical tablet and process for making thereof
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
AU4061702A
(en)
*
|
2001-05-15 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Dip coating compositions containing starch or dextrin
|
IL159813A0
(en)
*
|
2001-07-12 |
2004-06-20 |
Teva Pharma |
Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core
|
IL159812A0
(en)
*
|
2001-07-12 |
2004-06-20 |
Teva Pharma |
Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester in a controlled release core
|
US7838026B2
(en)
|
2001-09-28 |
2010-11-23 |
Mcneil-Ppc, Inc. |
Burst-release polymer composition and dosage forms comprising the same
|
CN100408029C
(zh)
*
|
2001-09-28 |
2008-08-06 |
麦克内尔-Ppc股份有限公司 |
有镶嵌部分的组合剂型
|
US7122143B2
(en)
*
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
US20030228368A1
(en)
*
|
2001-09-28 |
2003-12-11 |
David Wynn |
Edible solid composition and dosage form
|
US6837696B2
(en)
*
|
2001-09-28 |
2005-01-04 |
Mcneil-Ppc, Inc. |
Apparatus for manufacturing dosage forms
|
US20040146559A1
(en)
*
|
2002-09-28 |
2004-07-29 |
Sowden Harry S. |
Dosage forms having an inner core and outer shell with different shapes
|
US8309118B2
(en)
*
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
CA2409552A1
(en)
*
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
AU2002340470A1
(en)
|
2001-11-13 |
2003-05-26 |
Teva Pharmaceutical Industries, Ltd. |
L-dopa ethyl ester salts and uses thereof
|
AU2002346372A1
(en)
*
|
2001-11-13 |
2003-05-26 |
Teva Pharmaceutical Industries, Ltd. |
Process for the production of l-dopa ethyl ester
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
US20050215552A1
(en)
*
|
2002-05-17 |
2005-09-29 |
Gadde Kishore M |
Method for treating obesity
|
US20040166159A1
(en)
*
|
2002-05-29 |
2004-08-26 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
|
US20030224045A1
(en)
*
|
2002-05-29 |
2003-12-04 |
Chien-Hsuan Han |
Combination immediate release sustained release levodopa/carbidopa dosage forms
|
US20060013875A1
(en)
*
|
2002-05-29 |
2006-01-19 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
US7094427B2
(en)
*
|
2002-05-29 |
2006-08-22 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
US7893218B2
(en)
|
2003-06-16 |
2011-02-22 |
Stowers Institute For Medical Research |
Antibodies that specifically bind SOST peptides
|
US6902746B2
(en)
*
|
2002-07-03 |
2005-06-07 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same
|
US7429619B2
(en)
*
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
AU2003255890A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Ranbaxy Laboratories Limited |
Nitrofurantoin controlled release dosage form
|
US7309444B2
(en)
*
|
2002-08-29 |
2007-12-18 |
Stellar Technology Company |
Layered tablet water treatment compositions and method of use
|
US6852238B2
(en)
*
|
2002-08-29 |
2005-02-08 |
Steller Technology Company |
Layered tablet water treatment compositions and method of use
|
AU2003270393B2
(en)
*
|
2002-09-09 |
2008-03-20 |
Endo Pharmaceuticals Inc. |
Combined immediate release and extended relase analgesic composition
|
WO2004024184A1
(ja)
*
|
2002-09-11 |
2004-03-25 |
Takeda Pharmaceutical Company Limited |
徐放性製剤
|
US7807197B2
(en)
|
2002-09-28 |
2010-10-05 |
Mcneil-Ppc, Inc. |
Composite dosage forms having an inlaid portion
|
KR20050071517A
(ko)
*
|
2002-09-28 |
2005-07-07 |
맥네일-피피씨, 인코포레이티드 |
코어를 2개 갖는 개질된 방출성 투여 제형
|
US20040180086A1
(en)
*
|
2002-10-11 |
2004-09-16 |
Zebunnissa Ramtoola |
Gastro-retentive levodopa delivery form
|
US20040115265A1
(en)
*
|
2002-12-11 |
2004-06-17 |
Loutfy Benkerrour |
Multilayered tablet containing pravastatin and aspirin and method
|
JP4616009B2
(ja)
*
|
2002-12-26 |
2011-01-19 |
ポーゼン インコーポレイテッド |
NSAIDsおよびトリプタンを含有する多層剤型
|
SI2316456T1
(sl)
|
2003-04-29 |
2017-10-30 |
Orexigen Therapeutics, Inc. |
Sestavki za vplivanje na izgubo teže, ki obsegajo opioidni antagonist in bupropion
|
FR2855756B1
(fr)
*
|
2003-06-06 |
2005-08-26 |
Ethypharm Sa |
Comprime orodispersible multicouche
|
EP1631263B1
(fr)
*
|
2003-06-06 |
2014-02-26 |
Ethypharm |
Comprime orodispersible multicouche
|
AU2007202920B2
(en)
*
|
2003-06-19 |
2009-10-29 |
Aristocrat Technologies Australia Pty Limited |
A gaming system with a cashier terminal
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
US20050025825A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Xanodyne Pharmacal, Inc. |
Tranexamic acid formulations with reduced adverse effects
|
US7947739B2
(en)
|
2004-03-04 |
2011-05-24 |
Ferring B.V. |
Tranexamic acid formulations
|
US8022106B2
(en)
*
|
2004-03-04 |
2011-09-20 |
Ferring B.V. |
Tranexamic acid formulations
|
US20050244495A1
(en)
|
2004-03-04 |
2005-11-03 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US20090215898A1
(en)
*
|
2004-03-04 |
2009-08-27 |
Xanodyne Pharmaceuticals, Inc. |
Tranexamic acid formulations
|
US20050202079A1
(en)
*
|
2004-03-15 |
2005-09-15 |
Mylan Pharmaceuticals Inc. |
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
|
EP1591109B1
(en)
*
|
2004-04-30 |
2008-07-02 |
TopoTarget Germany AG |
Formulation comprising histone deacetylase inhibitor exhibiting biphasic release
|
EP1750647B1
(en)
|
2004-05-21 |
2014-11-19 |
Accu-Break Technologies, Inc. |
Pharmaceutical tablets having a separation mark positioned on the side of said tablets
|
TWI547431B
(zh)
*
|
2004-06-09 |
2016-09-01 |
史密斯克萊美占公司 |
生產藥物之裝置及方法
|
AU2007202381C1
(en)
*
|
2004-06-18 |
2010-03-11 |
Aristocrat Technologies Australia Pty Ltd |
Cashless reservation system
|
US9308164B2
(en)
*
|
2004-06-30 |
2016-04-12 |
Sovereign Pharmaceuticals, Llc |
Hyoscyamine dosage form
|
JP4681843B2
(ja)
*
|
2004-09-30 |
2011-05-11 |
日本臓器製薬株式会社 |
固形医薬製剤
|
US8858960B2
(en)
|
2004-11-19 |
2014-10-14 |
GlaxoSmithKline, LLC |
Method of producing a pharmaceutical product
|
US7344907B2
(en)
*
|
2004-11-19 |
2008-03-18 |
International Business Machines Corporation |
Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
|
MX2007006646A
(es)
*
|
2004-12-03 |
2007-11-16 |
Adherex Technologies Inc |
Metodos para administrar inhibidores de dihidropirimidina deshidrogenasa en combinacion con 5-fluorouracilo y profarmacos de 5-fluorouracilo.
|
US20060178349A1
(en)
*
|
2005-01-24 |
2006-08-10 |
Pozen Inc. |
Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
US20070036859A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Perry Ronald L |
Sustained release antihistamine and decongestant composition
|
WO2007058660A1
(en)
*
|
2005-11-18 |
2007-05-24 |
Accu-Break Technologies, Inc. |
Segmented pharmaceutical dosage forms
|
EP2135603B1
(en)
*
|
2005-11-22 |
2013-01-02 |
Orexigen Therapeutics, Inc. |
Compositions and methods for increasing insulin sensitivity
|
CA2635313C
(en)
|
2005-12-29 |
2013-12-31 |
Osmotica Corp. |
Triple combination release multi-layered tablet
|
DE102006058252A1
(de)
*
|
2006-12-08 |
2008-06-12 |
Aris Handels Gmbh |
Vorrichtung zur Insektenbekämpfung, insbesondere zur Bekämpfung von Fliegen
|
CN101410012A
(zh)
*
|
2006-03-28 |
2009-04-15 |
杰佛林制药公司 |
低剂量的非甾体抗炎药和β-环糊精的制剂
|
WO2007112272A2
(en)
*
|
2006-03-28 |
2007-10-04 |
Javelin Pharmaceuticals, Inc. |
Formulations of low dose diclofenac and beta-cyclodextrin
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
MX2008016349A
(es)
*
|
2006-06-19 |
2009-01-28 |
Accu Break Technologies Inc |
Formas segmentadas de dosificacion farmaceutica.
|
CA2665841C
(en)
|
2006-10-09 |
2016-04-05 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
PT2124556E
(pt)
*
|
2006-10-09 |
2014-12-03 |
Charleston Lab Inc |
Composições farmacêuticas
|
KR101735466B1
(ko)
*
|
2006-11-09 |
2017-05-15 |
오렉시젠 세러퓨틱스 인크. |
신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
|
KR20150082689A
(ko)
*
|
2006-11-09 |
2015-07-15 |
오렉시젠 세러퓨틱스 인크. |
단위 용량 팩키지
|
EP2083801A1
(en)
*
|
2006-11-30 |
2009-08-05 |
Accu-Break Technologies, Inc. |
Divisible osmotic dosage forms and methods of use
|
WO2009131553A2
(en)
|
2006-12-29 |
2009-10-29 |
Osteogenex Inc. |
Methods of altering bone growth by administration of sost or wise antagonist or agonist
|
WO2009002867A2
(en)
*
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
CN101842085B
(zh)
|
2007-10-31 |
2013-01-30 |
麦克内尔-Ppc股份有限公司 |
口腔崩解剂型
|
CN101910113A
(zh)
|
2007-12-28 |
2010-12-08 |
怡百克制药公司 |
左旋多巴控释制剂及其用途
|
JP5714910B2
(ja)
|
2008-01-09 |
2015-05-07 |
チャールストン ラボラトリーズ,インコーポレイテッド |
薬学的組成物
|
US20090280175A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Proton Pump Inhibitor Tablets
|
CA2725930A1
(en)
*
|
2008-05-30 |
2009-12-30 |
Orexigen Therapeutics, Inc. |
Methods for treating visceral fat conditions
|
AU2009281752B2
(en)
*
|
2008-08-15 |
2016-11-17 |
Depomed Inc. |
Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders
|
TWI473610B
(zh)
*
|
2008-10-28 |
2015-02-21 |
Twi Biotechnology Inc |
包含雙醋瑞因(diacerein)之醫藥組合物
|
US20100233259A1
(en)
*
|
2008-12-12 |
2010-09-16 |
Pascal Grenier |
Dosage form of ropinirole
|
US20100280117A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Xanodyne Pharmaceuticals, Inc. |
Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
|
CA2767576C
(en)
|
2009-07-08 |
2020-03-10 |
Charleston Laboratories Inc. |
Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
|
US20110070301A1
(en)
*
|
2009-09-24 |
2011-03-24 |
Luber Joseph R |
Orally transformable tablets
|
US8313768B2
(en)
*
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
US8858210B2
(en)
|
2009-09-24 |
2014-10-14 |
Mcneil-Ppc, Inc. |
Manufacture of variable density dosage forms utilizing radiofrequency energy
|
CN102724878A
(zh)
*
|
2010-01-11 |
2012-10-10 |
奥雷西根治疗公司 |
在重度抑郁症患者中提供体重减轻疗法的方法
|
EP2528604B1
(en)
|
2010-01-29 |
2017-11-22 |
The Regents of the University of California |
Acyl piperidine inhibitors of soluble epoxide hydrolase
|
AU2011236548A1
(en)
*
|
2010-04-07 |
2012-11-01 |
Lupin Limited |
Controlled release pharmaceutical compositions of tapentadol
|
IT1406328B1
(it)
*
|
2010-12-23 |
2014-02-21 |
S I I T S R L Ora S I I T S R L Unipersonale |
Compressa multistrato a rilascio diversificato
|
US9029401B2
(en)
|
2011-02-14 |
2015-05-12 |
The Regents Of The University Of California |
Sorafenib derivatives as sEH inhibitors
|
EP2508174A1
(en)
|
2011-04-06 |
2012-10-10 |
Ljiljana Sovic Brkicic |
Pharmaceutical composition
|
DK3453711T3
(da)
|
2011-09-02 |
2021-10-18 |
Univ California |
Llp2a-bisphosphonatkonjugater til behandling mod osteoporose
|
CN104093708B
(zh)
|
2012-02-01 |
2016-11-09 |
加利福尼亚大学董事会 |
可溶性环氧化物水解酶的酰基哌啶抑制剂
|
US9445971B2
(en)
|
2012-05-01 |
2016-09-20 |
Johnson & Johnson Consumer Inc. |
Method of manufacturing solid dosage form
|
US9511028B2
(en)
|
2012-05-01 |
2016-12-06 |
Johnson & Johnson Consumer Inc. |
Orally disintegrating tablet
|
DK3730132T3
(da)
|
2012-06-06 |
2022-08-08 |
Nalpropion Pharmaceuticals Llc |
Sammensætning til anvendelse ved en fremgangsmåde til behandling af overvægt og obesitas hos patienter med høj kardiovaskulær risiko
|
ITMI20121263A1
(it)
|
2012-07-19 |
2014-01-20 |
Recordati Ind Chimica E Farma Ceutica S P A |
Forma farmaceutica multistrato
|
CA2899247C
(en)
|
2013-03-14 |
2023-04-04 |
Osteoqc Inc. |
Alkyl-amine harmine derivatives for promoting bone growth
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
CA2926082C
(en)
|
2013-10-07 |
2022-06-14 |
Impax Laboratories, Inc. |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
CN106068120B
(zh)
|
2014-01-10 |
2021-03-23 |
强生消费者公司 |
使用射频和有损耗的包衣粒子制造片剂的方法
|
EP2937096B1
(en)
|
2014-04-23 |
2019-08-21 |
Julius-Maximilians-Universität Würzburg |
Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity
|
US9839212B2
(en)
|
2015-04-16 |
2017-12-12 |
Bio-Lab, Inc. |
Multicomponent and multilayer compacted tablets
|
WO2017062997A1
(en)
|
2015-10-09 |
2017-04-13 |
Reckitt Benckiser Llc |
Pharmaceutical formulation
|
US10179109B2
(en)
|
2016-03-04 |
2019-01-15 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
|
AU2017246334C1
(en)
*
|
2016-04-04 |
2022-11-17 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using Trapidil
|
US10493026B2
(en)
|
2017-03-20 |
2019-12-03 |
Johnson & Johnson Consumer Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|
CA3109104A1
(en)
|
2018-08-14 |
2020-02-20 |
Osteoqc Inc. |
Fluoro .beta.-carboline compounds
|
CA3108714A1
(en)
|
2018-08-14 |
2020-02-20 |
Osteoqc Inc. |
Pyrrolo - dipyridine compounds
|